These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24490149)

  • 21. Refinement of breast cancer risk prediction with concordant leading edge subsets from prognostic gene signatures.
    Huang CC; Tu SH; Lien HH; Huang CS; Huang CJ; Lai LC; Tsai MH; Chuang EY
    Breast Cancer Res Treat; 2014 Sep; 147(2):353-70. PubMed ID: 25158930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the microarray gene expression for breast cancer progression after the application modified logistic regression.
    Morais-Rodrigues F; Silv Erio-Machado R; Kato RB; Rodrigues DLN; Valdez-Baez J; Fonseca V; San EJ; Gomes LGR; Dos Santos RG; Vinicius Canário Viana M; da Cruz Ferraz Dutra J; Teixeira Dornelles Parise M; Parise D; Campos FF; de Souza SJ; Ortega JM; Barh D; Ghosh P; Azevedo VAC; Dos Santos MA
    Gene; 2020 Feb; 726():144168. PubMed ID: 31759986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA-Seq of Circulating Tumor Cells in Stage II-III Breast Cancer.
    Lang JE; Ring A; Porras T; Kaur P; Forte VA; Mineyev N; Tripathy D; Press MF; Campo D
    Ann Surg Oncol; 2018 Aug; 25(8):2261-2270. PubMed ID: 29868978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients.
    Ankney JA; Xie L; Wrobel JA; Wang L; Chen X
    BMC Med Genomics; 2019 May; 12(1):78. PubMed ID: 31146747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PCA-PAM50 improves consistency between breast cancer intrinsic and clinical subtyping reclassifying a subset of luminal A tumors as luminal B.
    Raj-Kumar PK; Liu J; Hooke JA; Kovatich AJ; Kvecher L; Shriver CD; Hu H
    Sci Rep; 2019 May; 9(1):7956. PubMed ID: 31138829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased RNA Expression of von Willebrand Factor Gene Is Associated With Infiltrating Lobular Breast Cancer and Normal PAM50 Subtype.
    Lehrer S; Green S; Dembitzer FR; Rheinstein PH; Rosenzweig KE
    Cancer Genomics Proteomics; 2019; 16(3):147-153. PubMed ID: 31018945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 50-gene intrinsic subtype classifier for prognosis and prediction of benefit from adjuvant tamoxifen.
    Chia SK; Bramwell VH; Tu D; Shepherd LE; Jiang S; Vickery T; Mardis E; Leung S; Ung K; Pritchard KI; Parker JS; Bernard PS; Perou CM; Ellis MJ; Nielsen TO
    Clin Cancer Res; 2012 Aug; 18(16):4465-72. PubMed ID: 22711706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer.
    Cespedes Feliciano EM; Kwan ML; Kushi LH; Chen WY; Weltzien EK; Castillo AL; Sweeney C; Bernard PS; Caan BJ
    Cancer; 2017 Jul; 123(13):2535-2542. PubMed ID: 28295245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-class tumor classification by discriminant partial least squares using microarray gene expression data and assessment of classification models.
    Tan Y; Shi L; Tong W; Hwang GT; Wang C
    Comput Biol Chem; 2004 Jul; 28(3):235-44. PubMed ID: 15261154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular subtyping for clinically defined breast cancer subgroups.
    Zhao X; Rødland EA; Tibshirani R; Plevritis S
    Breast Cancer Res; 2015 Feb; 17(1):29. PubMed ID: 25849221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas.
    López-Knowles E; Gao Q; Cheang MC; Morden J; Parker J; Martin LA; Pinhel I; McNeill F; Hills M; Detre S; Afentakis M; Zabaglo L; Dodson A; Skene A; Holcombe C; Robertson J; Smith I; Bliss JM; Dowsett M;
    Breast Cancer Res; 2016 Apr; 18(1):39. PubMed ID: 27036195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens.
    Nielsen T; Wallden B; Schaper C; Ferree S; Liu S; Gao D; Barry G; Dowidar N; Maysuria M; Storhoff J
    BMC Cancer; 2014 Mar; 14():177. PubMed ID: 24625003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stratification of Breast Cancer by Integrating Gene Expression Data and Clinical Variables.
    He Z; Zhang J; Yuan X; Xi J; Liu Z; Zhang Y
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30754661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression.
    Kwan ML; Kroenke CH; Sweeney C; Bernard PS; Weltzien EK; Castillo A; Factor RE; Maxfield KS; Stijleman IJ; Kushi LH; Quesenberry CP; Habel LA; Caan BJ
    BMC Cancer; 2015 Apr; 15():278. PubMed ID: 25884832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Few-shot genes selection: subset of PAM50 genes for breast cancer subtypes classification.
    Okimoto LYS; Mendonca-Neto R; Nakamura FG; Nakamura EF; Fenyö D; Silva CT
    BMC Bioinformatics; 2024 Mar; 25(1):92. PubMed ID: 38429657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Everolimus plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO-2.
    Prat A; Brase JC; Cheng Y; Nuciforo P; Paré L; Pascual T; Martínez D; Galván P; Vidal M; Adamo B; Hortobagyi GN; Baselga J; Ciruelos E
    Oncologist; 2019 Jul; 24(7):893-900. PubMed ID: 30679318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Novel Breast Cancer Subtype-Specific Biomarkers by Integrating Genomics Analysis of DNA Copy Number Aberrations and miRNA-mRNA Dual Expression Profiling.
    Li D; Xia H; Li ZY; Hua L; Li L
    Biomed Res Int; 2015; 2015():746970. PubMed ID: 25961039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A potential prognostic long non-coding RNA signature to predict metastasis-free survival of breast cancer patients.
    Sun J; Chen X; Wang Z; Guo M; Shi H; Wang X; Cheng L; Zhou M
    Sci Rep; 2015 Nov; 5():16553. PubMed ID: 26549855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agreement in risk prediction between the 21-gene recurrence score assay (Oncotype DX®) and the PAM50 breast cancer intrinsic Classifier™ in early-stage estrogen receptor-positive breast cancer.
    Kelly CM; Bernard PS; Krishnamurthy S; Wang B; Ebbert MT; Bastien RR; Boucher KM; Young E; Iwamoto T; Pusztai L
    Oncologist; 2012; 17(4):492-8. PubMed ID: 22418568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of key genes relevant to the prognosis of ER-positive and ER-negative breast cancer based on a prognostic prediction system.
    Xiao B; Hang J; Lei T; He Y; Kuang Z; Wang L; Chen L; He J; Zhang W; Liao Y; Sun Z; Li L
    Mol Biol Rep; 2019 Apr; 46(2):2111-2119. PubMed ID: 30888555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.